E-LIB Suche - Ergebnisse für: Crabb, Simon

1

Capivasertib in combination with enzalutamide for metastati..:

Rescigno, Pasquale ; Porta, Nuria ; Finneran, Laura...
European Journal of Cancer. 205 (2024) - p. 114103 , 2024

Link: https://doi.org/10.1016/..

2

Dose escalation of tolinapant (ASTX660) in combination with..:

Hoskin, Peter ; Lee, Marina ; Dunkley, Denise...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Global real-world experiences with pembrolizumab in advance..:

Massari, Francesco ; Santoni, Matteo ; Takeshita, Hideki...
Cancer Immunology, Immunotherapy. 73 (2024) 6 - p. , 2024

Link: https://doi.org/10.1007/..

4

Cost–effectiveness analysis for avelumab first-line mainten..:

Critchlow, Simone ; Bullement, Ash ; Crabb, Simon...
Future Oncology. 20 (2024) 8 - p. 459-470 , 2024

Link: https://doi.org/10.2217/..

5

Verification of molecular subtyping of bladder cancer in th..:

Griffin, Jon ; Down, Jenny ; Quayle, Lewis A...
The Journal of Pathology: Clinical Research. 10 (2024) 2 - p. , 2024

Link: https://doi.org/10.1002/..

6

Biomarkers associated with survival in patients with platin..:

Jackson-Spence, Francesca ; Ackerman, Charlotte ; Jones, Robert...
Urologic Oncology: Seminars and Original Investigations. , 2024

Link: https://doi.org/10.1016/..

7

Systemic anticancer therapy for urothelial carcinoma: UK on..:

Jones, Robert J. ; Crabb, Simon J. ; Linch, Mark...
British Journal of Cancer. 130 (2024) 6 - p. 897-907 , 2024

Link: https://doi.org/10.1038/..

8

PARP Inhibitors for Metastatic Urothelial Carcinoma: A Syst..:

Crabb, Simon J. ; Khalid, Taha ; Woods, Lois..
Bladder Cancer. 9 (2023) 4 - p. 365-376 , 2023

Link: https://doi.org/10.3233/..

9

A multicentre randomised controlled trial of a guided self-..:

Crabb, Simon ; Morgan, Alannah ; Hunter, Myra S....
Trials. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

10

Publisher Correction: Clinical efficacy and biomarker analy..:

Powles, Thomas ; Kockx, Mark ; Rodriguez-Vida, Alejo...
Nature Medicine. 29 (2023) 12 - p. 3271-3271 , 2023

Link: https://doi.org/10.1038/..

11

Use of concomitant proton pump inhibitors, statins or metfo..:

Fiala, Ondřej ; Buti, Sebastiano ; Takeshita, Hideki...
Cancer Immunology, Immunotherapy. 72 (2023) 11 - p. 3665-3682 , 2023

Link: https://doi.org/10.1007/..

12

Using the AR-V7 biomarker to determine treatment in metasta..:

Gravestock, Paul ; Clark, Emma ; Morton, Miranda...
NIHR Open Research. 2 (2023) - p. 49 , 2023

Link: https://doi.org/10.3310/..

13

Real-world effectiveness of pembrolizumab as first-line the..:

Santoni, Matteo ; Myint, Zin W. ; Büttner, Thomas...
Cancer Immunology, Immunotherapy. 72 (2023) 9 - p. 2961-2970 , 2023

Link: https://doi.org/10.1007/..

14

Patient experience of surveillance following radical treatm..:

Hack, Joanna ; Douglas, James ; Makaroff, Lydia...
BJU International. 133 (2023) 4 - p. 410-412 , 2023

Link: https://doi.org/10.1111/..

15

Evaluating atezolizumab in patients with urinary tract squa..:

Crabb, Simon ; Wickens, Robin ; Jane-Bibby, Sarah...
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..